Challenger (CEL) is held by 1 ASX ETF. Over the last year it fell 47.9%: on $10,000, −$4788. We explain 10 big moves in that time.
About CEL
- SectorMaterials
- IndustryMaterials
- Size$246.4m
- Held by1 ETF
- Big moves10 in 1Y
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- −8.0%25 Jun 2026· Capital Raise
Challenger Gold's stock fell after announcing an institutional placement and subsequent share dilution, requiring an EGM to ratify the new share issues.
- −7.1%20 Jun 2026· Sector Flow
No direct news specific to Challenger Gold explains the drop; movement likely sector/explorer sentiment spillover.
- −7.4%10 Jun 2026· Sector Flow
Challenger Gold's stock declined amid a broader small-cap sector shift, with investor attention focused on Imugene's FDA Fast Track news, potentially drawing capital away from gold explorers.
- +11.1%2 Jun 2026· Operational
Challenger Gold poured first gold at its Hualilán project, a key operational milestone.
- −11.5%29 May 2026· Sector Flow
Challenger Gold's stock fell 11.54% on May 28, 2026, likely due to sector-wide investor rotation out of ASX resources, as news articles focus on healthcare/biotech stocks and unrelated mining movers with no company-specific negative announcements.
- −7.7%21 May 2026· Capital Raise
A share price decline followed the announcement of an AUD85 million equity raising, which typically dilutes existing shareholders.
- +8.0%7 May 2026· Unknown
No definitive cause identified; likely driven by positive sector or company momentum from recent coverage.
- −6.3%21 Apr 2026· Unknown
No direct news explains the decline; likely due to sector or commodity moves not covered in the articles.
- +6.9%11 Apr 2026· Analyst
Challenger Gold shares rose sharply on April 10, 2026, likely due to positive sentiment and analyst coverage highlighting the company as a potential breakout gold producer.
- +7.4%31 Mar 2026· Unknown
No clear news catalyst found for the price move; likely driven by sector or market sentiment rather than company-specific news.
Held by 1 ETF
Of every $10,000 in each fund, how much is in CEL today.
Why did CEL fall 7.4% on 10 Jun 2026?
Challenger
Challenger Gold's stock declined amid a broader small-cap sector shift, with investor attention focused on Imugene's FDA Fast Track news, potentially drawing capital away from gold explorers.
The news articles are all about Imugene, a biotech peer, and do not directly mention Challenger Gold. The price drop and volume spike for a gold explorer on a day when biotech headlines dominated suggest a sector rotation or sentiment shift rather than company-specific news. However, without explicit evidence of a sector-wide selloff or any Challenger Gold announcement, the cause remains circumstantial.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
Evidence
News coverage
What it did to the 1 ETF holding CEL
On $10,000 in each fund, at the weight it holds today